About Recursion Pharmaceuticals, Inc. 
Recursion Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 47 Schemes (25.45%)
Foreign Institutions
Held by 154 Foreign Institutions (27.43%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
36 Million
(Quarterly Results - Dec 2025)
Net Profit:
-108 Million
Pharmaceuticals & Biotechnology
USD 1,780 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.60
-68.35%
1.70






